Literature DB >> 28682733

A Qualitative Study Examining Experiences and Dilemmas in Concealment and Disclosure of People Living With Serious Mental Illness.

Shani Bril-Barniv1, Galia S Moran2, Adi Naaman1,3, David Roe1, Orit Karnieli-Miller4.   

Abstract

People with mental illnesses face the dilemma of whether to disclose or conceal their diagnosis, but this dilemma was scarcely researched. To gain in-depth understanding of this dilemma, we interviewed 29 individuals with mental illnesses: 16 with major depression/bipolar disorders and 13 with schizophrenia. Using a phenomenological design, we analyzed individuals' experiences, decision-making processes, and views of gains and costs regarding concealment and disclosure of mental illness. We found that participants employed both positive and negative disclosure/concealment practices. Positive practices included enhancing personal recovery, community integration, and/or supporting others. Negative practices occurred in forced, uncontrolled situations. We also identified various influencing factors, including familial norms of sharing, accumulated experiences with disclosure, and ascribed meaning to diagnosis. Based on these findings, we deepen the understanding about decision-making processes and the consequences of disclosing or concealing mental illness. We discuss how these finding can help consumers explore potential benefits and disadvantages of mental illness disclosure/concealment occurrences.

Entities:  

Keywords:  Israel; concealment; decision;; disclosure; mental illness diagnosis; phenomenological qualitative research; positive/negative; recovery; stigma

Mesh:

Year:  2016        PMID: 28682733     DOI: 10.1177/1049732316673581

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  8 in total

1.  The mental health consumer movement and peer providers in Israel.

Authors:  G S Moran
Journal:  Epidemiol Psychiatr Sci       Date:  2018-04-16       Impact factor: 6.892

Review 2.  Unravelling the Complexities of Workplace Disclosure Among Persons with Non-Visible Disabilities and Illnesses: A Qualitative Meta-Ethnography.

Authors:  Vanessa Tomas; Hiba Ahmed; Sally Lindsay
Journal:  J Occup Rehabil       Date:  2022-01-17

3.  Effects of contact-based mental illness stigma reduction programs: age, gender, and Asian, Latino, and White American differences.

Authors:  Eunice C Wong; Rebecca L Collins; Jennifer L Cerully; Jennifer W Yu; Rachana Seelam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-12-02       Impact factor: 4.328

4.  The Three Cs of Disclosing Serious Mental Illness at Work: Control, Conditions, Costs.

Authors:  Marjorie L Baldwin
Journal:  Psychiatr Serv       Date:  2021-01-20       Impact factor: 3.084

5.  The experience of patients with bipolar disorder from diagnosis disclosure: A qualitative study.

Authors:  Azam Zolfi Kashani; Hadi Ranjbar; Maryam Rasoulian; Amir Shabani; Mohammad Ghadirivasfi; Homa Mohammadsadeghi
Journal:  Med J Islam Repub Iran       Date:  2020-04-20

Review 6.  Honest, Open, Proud to support disclosure decisions and to decrease stigma's impact among people with mental illness: conceptual review and meta-analysis of program efficacy.

Authors:  Nicolas Rüsch; Markus Kösters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-04-24       Impact factor: 4.328

7.  A Critical Perspective on Mental Health News in Six European Countries: How Are "Mental Health/Illness" and "Mental Health Literacy" Rhetorically Constructed?

Authors:  Laura Van Beveren; Kris Rutten; Gunnel Hensing; Ntani Spyridoula; Viktor Schønning; Malin Axelsson; Claudi Bockting; Ann Buysse; Ine De Neve; Mattias Desmet; Alexis Dewaele; Theodoros Giovazolias; Dewi Hannon; Konstantinos Kafetsios; Reitske Meganck; Simon Øverland; Sofia Triliva; Joke Vandamme
Journal:  Qual Health Res       Date:  2020-04-04

8.  Attitudes towards disclosing a mental illness: impact on quality of life and recovery.

Authors:  Lea Mayer; Patrick W Corrigan; Daniela Eisheuer; Nathalie Oexle; Nicolas Rüsch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-04-24       Impact factor: 4.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.